A matter of life and cell death.

In multicellular organisms, mutations in somatic cells affecting critical genes that regulate cell proliferation and survival cause fatal cancers. Repair of the damage is one obvious option, although the relative inconsequence of individual cells in metazoans means that it is often a "safer" strategy to ablate the offending cell. Not surprisingly, corruption of the machinery that senses or implements DNA damage greatly predisposes to cancer. Nonetheless, even when oncogenic mutations do occur, there exist potent mechanisms that limit the expansion of affected cells by suppressing their proliferation or triggering their suicide. Growing understanding of these innate mechanisms is suggesting novel therapeutic strategies for cancer.

[1]  A. Levine,et al.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.

[2]  B. Stillman,et al.  Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins , 1987, Journal of virology.

[3]  M. Noble,et al.  Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. , 1988, The EMBO journal.

[4]  H. Ruley,et al.  Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Ohlsson,et al.  Insulin‐like growth factor 2 and short‐range stimulatory loops in control of human placental growth. , 1989, The EMBO journal.

[6]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[7]  W. Brown,et al.  Structure and polymorphism of human telomere-associated DNA , 1990, Cell.

[8]  J. Nevins,et al.  Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. , 1991, Genes & development.

[9]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[10]  P. Duerksen-Hughes,et al.  The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells , 1991, Journal of virology.

[11]  G. Hicks,et al.  Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest , 1991, Molecular and cellular biology.

[12]  S. Korsmeyer,et al.  The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[14]  D. Green,et al.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.

[15]  Yi-Song Wang,et al.  Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. , 1993, Molecular and cellular biology.

[17]  G. Evan,et al.  The c‐Myc protein induces cell cycle progression and apoptosis through dimerization with Max. , 1993, The EMBO journal.

[18]  S. Lowe,et al.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.

[19]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[20]  Yi-Song Wang,et al.  Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. , 1993, Oncogene.

[21]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. , 1994, Genes & development.

[23]  G. Evan,et al.  Oncogenes and cell death. , 1994, Current opinion in genetics & development.

[24]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[25]  H. Pan,et al.  Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.

[26]  K. Alitalo,et al.  c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha. , 1994, The EMBO journal.

[27]  G. Evan,et al.  c‐Myc‐induced apoptosis in fibroblasts is inhibited by specific cytokines. , 1994, The EMBO journal.

[28]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[29]  Stephen S. Gisselbrecht,et al.  Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. White,et al.  Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells , 1994, Journal of virology.

[31]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[32]  M. Karin,et al.  p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.

[33]  S. Estus,et al.  Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death , 1994, Neuron.

[34]  P. O'Connor,et al.  Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. , 1994, Oncogene.

[35]  G. Wahl,et al.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. , 1994, Genes & development.

[36]  M. Collins,et al.  Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. , 1994, Oncogene.

[37]  R. DePinho,et al.  p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens , 1994, Nature.

[38]  S. Bayley,et al.  Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. , 1994, Oncogene.

[39]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[40]  D. Campana,et al.  Copyright � 1995, American Society for Microbiology PITSLRE Protein Kinase Activity Is Associated with Apoptosis , 1994 .

[41]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[42]  J. Cleveland,et al.  The role of ornithine decarboxylase in c-Myc-induced apoptosis. , 1995, Current topics in microbiology and immunology.

[43]  J. Martinou,et al.  Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation , 1995, The Journal of cell biology.

[44]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[45]  G. Prendergast,et al.  c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.

[46]  A. Levine,et al.  Essential role for p53-mediated transcription in E1A-induced apoptosis. , 1995, Genes & development.

[47]  E. White,et al.  Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein , 1995, Molecular and cellular biology.

[48]  J. Roth,et al.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.

[49]  M. Israel,et al.  Inhibition of apoptosis by the retinoblastoma gene product. , 1995, The EMBO journal.

[50]  D. Lane,et al.  p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. , 1995, Oncogene.

[51]  L. Donehower,et al.  The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. , 1995, Oncogene.

[52]  Q. Dou,et al.  Failure to activate interleukin 1β‐converting enzyme‐like proteases and to cleave retinoblastoma protein in drug‐resistant cells , 1996, FEBS letters.

[53]  G. Gil-Gómez,et al.  Bax alpha perturbs T cell development and affects cell cycle entry of T cells. , 1996, The EMBO journal.

[54]  J. Acker,et al.  Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. , 1996, The EMBO journal.

[55]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[56]  P. Branton,et al.  Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. , 1996, Oncogene.

[57]  A. Braithwaite,et al.  The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras. , 1996, Oncogene.

[58]  C. Prives,et al.  A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.

[59]  T. Jacks,et al.  Targeted disruption of p107: functional overlap between p107 and Rb. , 1996, Genes & development.

[60]  T. Jacks,et al.  Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.

[61]  A. Porter,et al.  Specific cleavage of the retinoblastoma protein by an ICE‐like protease in apoptosis. , 1996, The EMBO journal.

[62]  D. Baltimore,et al.  Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.

[63]  A. Strasser,et al.  The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.

[64]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[65]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[66]  W. Lee,et al.  Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Sherr Cancer Cell Cycles , 1996, Science.

[68]  T. Graeber,et al.  Modulation of c-Myc activity and apoptosis in vivo. , 1996, Cancer research.

[69]  W. Kaelin,et al.  The cellular effects of E2F overexpression. , 1996, Current topics in microbiology and immunology.

[70]  G. Linette,et al.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[71]  T. Hermiston,et al.  Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis , 1996, Journal of virology.

[72]  P. Fallon,et al.  Retinoblastoma protein inhibits IFN-gamma induced apoptosis. , 1996, Oncogene.

[73]  K. Walsh,et al.  Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation , 1996, Science.

[74]  M. Greenberg,et al.  E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.

[75]  W. Ansorge,et al.  Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. , 1996, The EMBO journal.

[76]  E. White,et al.  The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. , 1996, Genes & development.

[77]  J. Nevins,et al.  Distinct roles for E2F proteins in cell growth control and apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  N. Hay,et al.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. , 1997, Genes & development.

[79]  N. Dyson,et al.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. , 1997, Genes & development.

[80]  A. Klippel,et al.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.

[81]  R. Baserga,et al.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal , 1997, Molecular and cellular biology.

[82]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[83]  S. Fulda,et al.  Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells , 1997, Leukemia.

[84]  P. Galle,et al.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.

[85]  K. Hunt,et al.  P53 Carcinoma Cell Lines and Does Not Require Factor E2f-1 Induces Apoptosis in Human Breast and Ovarian Adenovirus-mediated Overexpression of the Transcription Updated Version Citing Articles E-mail Alerts Adenovirus-mediated Overexpression of the Transcription Factor E2f-1 Induces Apoptosis in Hum , 2013 .

[86]  C. Dionne,et al.  p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc. , 1997, Cancer research.

[87]  David R. Kaplan,et al.  Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.

[88]  S. Lowe,et al.  Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Yusuke Nakamura,et al.  A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis , 1997, Oncogene.

[90]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[91]  Seamus J. Martin,et al.  Degradation of Retinoblastoma Protein in Tumor Necrosis Factor- and CD95-induced Cell Death* , 1997, The Journal of Biological Chemistry.

[92]  A. Sarasin,et al.  Human cancer and DNA repair-deficient diseases. , 1997, Cancer detection and prevention.

[93]  A. Lloyd,et al.  Cooperating oncogenes converge to regulate cyclin/cdk complexes. , 1997, Genes & development.

[94]  D. Kirn,et al.  ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents , 1997, Nature Medicine.

[95]  M. Capogrossi,et al.  p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system. , 1997, Experimental cell research.

[96]  M. Oren,et al.  p53; from inductive signal to cellular effect. , 1997, Current opinion in genetics & development.

[97]  S. Korsmeyer,et al.  bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  I. Herr,et al.  The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.

[99]  Yi-Te Hsu,et al.  Movement of Bax from the Cytosol to Mitochondria during Apoptosis , 1997, The Journal of cell biology.

[100]  I. Herr,et al.  Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). , 1997, Blood.

[101]  L. Truong,et al.  Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. , 1997, The Journal of clinical investigation.

[102]  P. Cohen,et al.  Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Turchi,et al.  Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. , 1997, Cancer research.

[104]  D. Hunting,et al.  The apoptotic and transcriptional transactivation activities of p53 can be dissociated. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[105]  Y. Sun,et al.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.

[106]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[107]  Philip R. Cohen,et al.  Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216 , 1997, FEBS letters.

[108]  K. Helin,et al.  Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.

[109]  Daniel E. Johnson,et al.  Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family , 1997, Journal of cellular biochemistry.

[110]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis in extracts from drug-resistant cells. , 1997, Genes & development.

[111]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[112]  A. Strasser,et al.  The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry , 1997, The EMBO journal.

[113]  D. Haber,et al.  Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.

[114]  Q. Dou,et al.  Characterization of interior cleavage of retinoblastoma protein in apoptosis , 1997, Journal of cellular biochemistry.

[115]  B. Vojtesek,et al.  Up‐regulation of Fas (CD95) in human p53wild‐type cancer cells treated with ionizing radiation , 1997, International journal of cancer.

[116]  V. D’Agati,et al.  C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.

[117]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[118]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[119]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[120]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[121]  J. Flint,et al.  Viral transactivating proteins. , 1997, Annual review of genetics.

[122]  A. Strasser,et al.  Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. , 1997, Journal of immunology.

[123]  J. Cleveland,et al.  E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis , 1997, Molecular and cellular biology.

[124]  G. Evan,et al.  p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice , 1998, Current Biology.

[125]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[126]  J. Nevins,et al.  E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[127]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[128]  Kenneth G. C. Smith,et al.  A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes , 1998, The EMBO journal.

[129]  D. Green,et al.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.

[130]  L. Ellis,et al.  Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. , 1998, Cancer research.

[131]  Thomas A. Luger,et al.  Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L , 1998, The Journal of cell biology.

[132]  T. Jacks,et al.  Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice , 1998, Nature Genetics.

[133]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[134]  S. Jackson,et al.  DNA-dependent protein kinase. , 1997, The international journal of biochemistry & cell biology.